Our patent pending treatment target glial cells directly offering relief for many types of mental illnesses and cancer.

By inhibiting microglial activation, the neurodestructive effects of chronic inflammation could be reduced and allow for neuronal reconnection resulting in improvement in the symptoms in mental illness. Many studies suggest that there pharmaceutical treatments likeours can reduce microglial activation and ultimately help to mitigate the symptoms associated with mental illness.

People suffering from the following mental illnesses may benefit from our treatment.

Brain tumors need microglia to be activated before they can convince them to send out growth signals. Tumors then exploit these signals to enable their rapid growth. Instead of focusing in cancer therapies that poison cancer cells, we focus on inhibiting microglial activation to deprive the cancer cells of the growth signals it receives from the normal surrounding tissues. Research has shown that microglial cells produce more of hyaluronidase, an enzyme associated with tumor
growth (1). By inhbiting microglial activation leads to reduction of the tumor growth.

People suffering from the following mental illnesses may benefit from our treatment.